Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Insomnia
19%
African Cohort
38%
Anti-depression
25%
Antidepressant Therapy
25%
Antidepressants
96%
Arterial Elasticity
38%
Augmentation Index
23%
Bladder Dysfunction
38%
Breast Cancer Patients
38%
Chemotherapy
38%
Circulating Levels
38%
Concentration-dependent Toxicity
19%
Controlled Clinical Trial
25%
Depressive Disorder
76%
Diabetes Patients
38%
Diagnosis Treatment
19%
Discontinued Product
25%
Effective Treatment
44%
Endothelin 1 (ET-1)
38%
Ethnopharmacology
38%
Experimental Drugs
25%
Glimepiride
23%
High Peaks
19%
Inflammatory Cytokines
53%
Inflammatory Markers
38%
Insomnia
38%
Interleukin-1β
33%
Interleukin-6
20%
Interleukin-8
33%
Intervention-behavioral
19%
Local Data
25%
Local Use
25%
Metformin
38%
Neuroinflammation
25%
Overall Morbidity
25%
Pain Syndrome
19%
Pharmacological Management
76%
Pretoria
38%
Public Health Burden
19%
Pulse Wave Velocity Ratio
30%
Self-perceived
25%
Sensory Factors
19%
South Africa
52%
South African
64%
Subjective Cognitive Decline
38%
Toxicology
48%
Traditional Medicine
38%
Tumor Necrosis Factor-α
25%
Type 2 Diabetes Mellitus (T2DM)
23%
Urginea
38%
Medicine and Dentistry
Acute Pain
19%
Analgesia
19%
Antidepressant
38%
Arterial Stiffness
46%
Behavioral Change
19%
Cardiovascular Disease
25%
Cardiovascular Mortality
14%
Chronic Pain
38%
Cognitive Behavioral Therapy
38%
Diabetes
38%
Diseases
89%
Drug Megadose
8%
Drug Screening
38%
Effective Treatment
38%
Endothelin 1
38%
False Negative Result
8%
Formylmethionylleucylphenylalanine
8%
Glimepiride
23%
Glycon
38%
Herbaceous Agent
38%
Homeopathy
76%
Hypnotic
38%
Immune System
8%
In Vitro
38%
Inflammatory Cytokine
15%
Low Drug Dose
12%
Maturity Onset Diabetes of the Young
35%
Pain
38%
Perindopril
38%
Persistent Pain
38%
Phorbol 13 Acetate 12 Myristate
8%
Platelet
38%
Public Health
38%
Pulse Wave Velocity
100%
Republic of South Africa
54%
Screening Test
38%
Sleep Disorder
38%
Sleep Hygiene
38%
Sphygmomanometer
14%
Stroke
19%
Study Participant
14%
Surgical Approach
19%
Systolic Blood Pressure
12%
Tetrahydrocannabinol
8%
Traditional Medicine
76%
Treatment Group
12%
Type 2 Diabetes
15%
Urinary Tract Infection
38%
Urine Sampling
12%
Volunteer
23%
Pharmacology, Toxicology and Pharmaceutical Science
12-O-Tetradecanoylphorbol-13-Acetate
38%
Absence of Side Effects
25%
Acquired Immune Deficiency Syndrome
38%
Anticoagulant Agent
38%
Antidepressant
76%
Antidepressant
25%
Antiretrovirus Agent
12%
Antithrombocytic Agent
12%
Antithrombotic Therapy
38%
Antivitamin K
12%
Artery Thrombosis
12%
Blood Clotting Factor 10a
12%
Blood Stasis
12%
Controlled Clinical Trial
25%
Cystitis
5%
Depressive Disorder
76%
Drimia
38%
Drug Metabolizing Enzyme
12%
Endothelin 1
38%
Ethnopharmacology
38%
Fibrinolytic Agent
12%
Formylmethionylleucylphenylalanine
38%
Formylpeptide Receptor
38%
Hemostatic Agent
12%
High Performance Liquid Chromatography
38%
HIV
38%
Hospital Infection
5%
IC50
25%
Liliaceae
9%
Luminol
38%
Morbidity
25%
Normal Human
48%
Perindopril
38%
Pharmacogenetics
38%
Pharmacogenomics
38%
Protein Kinase C
38%
Pyelonephritis
5%
Thrombin
12%
Thrombosis
25%
Toxic Injury
86%
Toxicology
51%
Treatment Group
19%
Urinary Tract Infection
38%
Venous Thromboembolism
12%
